These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8687020)

  • 1. Parkinson's disease and free radicals. Mechanism of neurodegeneration and neuroprotection.
    Kondo T
    Ann N Y Acad Sci; 1996 Jun; 786():206-16. PubMed ID: 8687020
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
    Chiueh CC; Wu RM; Mohanakumar KP; Sternberger LM; Krishna G; Obata T; Murphy DL
    Ann N Y Acad Sci; 1994 Nov; 738():25-36. PubMed ID: 7832434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration.
    Dykens JA
    J Neurochem; 1994 Aug; 63(2):584-91. PubMed ID: 8035183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does oxidative stress participate in nerve cell death in Parkinson's disease?
    Hirsch EC
    Eur Neurol; 1993; 33 Suppl 1():52-9. PubMed ID: 8375433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
    Di Rocco A; Werner P
    Ann Neurol; 2000 Jan; 47(1):136-7. PubMed ID: 10632116
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration.
    Gutteridge JM
    Ann N Y Acad Sci; 1994 Nov; 738():201-13. PubMed ID: 7832429
    [No Abstract]   [Full Text] [Related]  

  • 8. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
    Leng A; Feldon J; Ferger B
    Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors which can play important role in pathogenesis of Parkinson disease].
    Koziorowski D; Jasztal J
    Neurol Neurochir Pol; 1999; 33(4):907-21. PubMed ID: 10612105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
    Fu Y; Ito M; Fujita Y; Ito M; Ichihara M; Masuda A; Suzuki Y; Maesawa S; Kajita Y; Hirayama M; Ohsawa I; Ohta S; Ohno K
    Neurosci Lett; 2009 Apr; 453(2):81-5. PubMed ID: 19356598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism and Parkinson's disease.
    Hirsch EC; Faucheux BA
    Mov Disord; 1998; 13 Suppl 1():39-45. PubMed ID: 9613717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease.
    Lan J; Jiang DH
    J Neural Transm (Vienna); 1997; 104(6-7):649-60. PubMed ID: 9444565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?
    Poirier J; Thiffault C
    Eur Neurol; 1993; 33 Suppl 1():38-43. PubMed ID: 8375431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration.
    Goto S; Hirano A; Matsumoto S
    Neurology; 1990 Jul; 40(7):1051-6. PubMed ID: 2192300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.
    Youdim MB; Ben-Shachar D; Eshel G; Finberg JP; Riederer P
    Adv Neurol; 1993; 60():259-66. PubMed ID: 8380520
    [No Abstract]   [Full Text] [Related]  

  • 18. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease.
    Morales I; Sabate M; Rodriguez M
    Eur J Neurosci; 2013 Jul; 38(1):2172-82. PubMed ID: 23565852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radical damage and oxidative stress in Huntington's disease.
    Borlongan CV; Kanning K; Poulos SG; Freeman TB; Cahill DW; Sanberg PR
    J Fla Med Assoc; 1996 May; 83(5):335-41. PubMed ID: 8666972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.
    Kuter K; Kratochwil M; Marx SH; Hartwig S; Lehr S; Sugawa MD; Dencher NA
    Arch Physiol Biochem; 2016 Dec; 122(5):238-256. PubMed ID: 27467289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.